Literature DB >> 23160024

Changes in Borrelia burgdorferi ELISA antibody over time in both antibiotic treated and untreated horses.

Thomas J Divers1, Amy L Grice, Hussni O Mohammed, Amy L Glaser, Bettina Wagner.   

Abstract

Changes in ELISA serology are frequently used to determine antibiotic treatment success for Lyme disease in horses. This concept was based upon a previous report showing a marked decline in ELISA values in experimentally infected and antibiotic-treated ponies. Changes in Lyme serology following antibiotic treatment in naturally infected horses have not been reported. The objective of this study was to compare Borrelia ELISA antibody concentrations in naturally exposed horses both before and following antibiotic treatment for Lyme disease. A retrospective study was performed comparing oxytetracycline- or doxycyclinetreated (n = 68) and untreated (n = 183) horses from a single equine practice and their change in Borrelia ELISA values over a similar time period. Antibiotictreated horses had a decline in ELISA values in comparison to control horses (P ≤ 0.05) and untreated horses were twice as likely to have their ELISA values increase (OR = 0.5; 95% C.I. = 0.3-0.9) compared to treated horses. The magnitude of the decline in ELISA units following treatments was small compared to that previously reported in experimentally infected and treated ponies. Field-exposed horses with high Borrelia burgdorferi ELISA values who are treated with either oxytetracycline or doxycycline can be expected to have only a small decline in ELISA values following treatment. Persistently high ELISA titres following appropriate treatments for Lyme disease may not, without appropriate clinical signs, be a reason for more prolonged treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23160024     DOI: 10.1556/AVet.2012.036

Source DB:  PubMed          Journal:  Acta Vet Hung        ISSN: 0236-6290            Impact factor:   0.955


  6 in total

1.  Brazilian borreliosis with special emphasis on humans and horses.

Authors:  Roberta Carvalho Basile; Natalino Hajime Yoshinari; Elenice Mantovani; Virgínia Nazário Bonoldi; Delphim da Graça Macoris; Antonio de Queiroz-Neto
Journal:  Braz J Microbiol       Date:  2016-10-04       Impact factor: 2.476

2.  Borrelia burgdorferi Infection and Lyme Disease in North American Horses: A Consensus Statement.

Authors:  T J Divers; R B Gardner; J E Madigan; S G Witonsky; J J Bertone; E L Swinebroad; S E Schutzer; A L Johnson
Journal:  J Vet Intern Med       Date:  2018-02-22       Impact factor: 3.333

3.  Evaluation of 2 ELISAs to determine Borrelia burgdorferi seropositivity in horses over a 12-month period.

Authors:  Megan Neely; Luis Arroyo; Claire Jardine; Katie Clow; Alison Moore; Murray Hazlett; J Scott Weese
Journal:  J Vet Diagn Invest       Date:  2021-05-27       Impact factor: 1.279

4.  Seroprevalence of Borrelia burgdorferi in Horses Presented for Coggins Testing in Southwest Virginia and Change in Positive Test Results Approximately 1 Year Later.

Authors:  R A Funk; R S Pleasant; S G Witonsky; D S Reeder; S R Werre; D R Hodgson
Journal:  J Vet Intern Med       Date:  2016-05-23       Impact factor: 3.333

5.  Serological Detection of Borrelia burgdorferi among Horses in Korea.

Authors:  Seung-Hun Lee; Sun-Hee Yun; Eunsang Choi; Yong-Soo Park; Sang-Eun Lee; Gil-Jae Cho; Oh-Deog Kwon; Dongmi Kwak
Journal:  Korean J Parasitol       Date:  2016-02-26       Impact factor: 1.341

6.  In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.

Authors:  Sanjie Caol; Thomas Divers; Mark Crisman; Yung-Fu Chang
Journal:  BMC Vet Res       Date:  2017-09-29       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.